Early estimation of acute myocardial infarct size soon after coronary reperfusion using emission computed tomography with technetium-99m pyrophosphate. 1987

T Hashimoto, and H Kambara, and T Fudo, and S Tamaki, and R Nohara, and Y Takatsu, and R Hattori, and S Tokunaga, and C Kawai
Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.

Early appearance of positive findings on a technetium-99m pyrophosphate scan has been shown to be associated with the presence of a reperfused acute myocardial infarction (AMI). Early technetium-99m pyrophosphate imaging was performed by emission computed tomography to evaluate reperfusion and to test the feasibility of estimating infarct size soon after coronary reperfusion based on acute positive tomographic findings. Twenty-seven patients with transmural AMI who were treated with intracoronary urokinase infusion followed by percutaneous transluminal coronary angioplasty underwent pyrophosphate imaging 8.7 +/- 2.1 hours after the onset of AMI. None of the 8 patients in whom reperfusion was unsuccessful had acute positive findings. Of 19 patients in whom reperfusion was successful, 17 had acute positive findings (p less than 0.001). In these 17, tomographic infarct volumes were determined from reconstructed transaxial images. The threshold for areas of increased pyrophosphate uptake within the infarct was set at 60% of peak activity by the computerized edge-detection algorithm. The total number of pixels in all transaxial sections showing increased tracer uptake were added and multiplied by a size factor and 1.05 g/cm3 muscle to determine infarct volume. The correlations of tomographic infarct volumes with peak serum creatine kinase (CK) levels (r = 0.82) and with cumulative release of CK-MB isoenzyme (r = 0.89) were good. Moreover, the time to positive imaging was significantly shorter than that to peak CK level (8.5 +/- 2.3 vs 10.4 +/- 2.2 hours, p less than 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011756 Diphosphates Inorganic salts of phosphoric acid that contain two phosphate groups. Diphosphate,Pyrophosphate Analog,Pyrophosphates,Pyrophosphate Analogs,Analog, Pyrophosphate
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T Hashimoto, and H Kambara, and T Fudo, and S Tamaki, and R Nohara, and Y Takatsu, and R Hattori, and S Tokunaga, and C Kawai
April 1989, Kaku igaku. The Japanese journal of nuclear medicine,
T Hashimoto, and H Kambara, and T Fudo, and S Tamaki, and R Nohara, and Y Takatsu, and R Hattori, and S Tokunaga, and C Kawai
July 1984, The American journal of cardiology,
T Hashimoto, and H Kambara, and T Fudo, and S Tamaki, and R Nohara, and Y Takatsu, and R Hattori, and S Tokunaga, and C Kawai
September 1986, Journal of cardiography,
T Hashimoto, and H Kambara, and T Fudo, and S Tamaki, and R Nohara, and Y Takatsu, and R Hattori, and S Tokunaga, and C Kawai
September 1986, Journal of cardiography,
T Hashimoto, and H Kambara, and T Fudo, and S Tamaki, and R Nohara, and Y Takatsu, and R Hattori, and S Tokunaga, and C Kawai
July 1984, British heart journal,
T Hashimoto, and H Kambara, and T Fudo, and S Tamaki, and R Nohara, and Y Takatsu, and R Hattori, and S Tokunaga, and C Kawai
March 1999, Japanese circulation journal,
T Hashimoto, and H Kambara, and T Fudo, and S Tamaki, and R Nohara, and Y Takatsu, and R Hattori, and S Tokunaga, and C Kawai
January 1993, Japanese circulation journal,
T Hashimoto, and H Kambara, and T Fudo, and S Tamaki, and R Nohara, and Y Takatsu, and R Hattori, and S Tokunaga, and C Kawai
September 1982, The American journal of cardiology,
T Hashimoto, and H Kambara, and T Fudo, and S Tamaki, and R Nohara, and Y Takatsu, and R Hattori, and S Tokunaga, and C Kawai
September 1982, Journal of cardiography,
T Hashimoto, and H Kambara, and T Fudo, and S Tamaki, and R Nohara, and Y Takatsu, and R Hattori, and S Tokunaga, and C Kawai
December 1984, The American journal of cardiology,
Copied contents to your clipboard!